A Partially Blind Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal 4-component Investigational Vaccine (GSK2392102A) in Healthy Adults
The purpose of this study is to evaluate the safety, reactogenicity and immunogenicity of several formulations of an investigational Staphylococcal vaccine.
100 项与 GSK2392105A 相关的临床结果
100 项与 GSK2392105A 相关的转化医学
100 项与 GSK2392105A 相关的专利(医药)
100 项与 GSK2392105A 相关的药物交易